Press release
Hepatitis E Diagnostic Tests Market Rugged Expansion Foreseen by 2024
The global market for hepatitis E diagnostic tests is treading a growth path as the prevalence of hepatitis E, especially in resource-poor regions is on the rise. Hepatitis E which is caused due to hepatitis E virus is a chief cause of mortality and morbidity in the developing world. Lack of proper sanitation and frequent instances of water contamination in these countries are leading causes of infections and diseases such as hepatitis E. This has stoked demand for diagnostic tests for hepatitis E, especially among individuals between 15 and 40 years.
The hepatitis E diagnostic tests market is appropriately segmented based on test type, end user, and geography.
The report on the hepatitis E diagnostic tests market compiled by seasoned analysts examines every possible aspect that could influence the growth of this market over the forecast timeframe. The various segments under different categories have been studied and the profitability of key ones presented over the remaining.
Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=S&rep_id=3077
Global Hepatitis E Diagnostic Tests Market: Trends and Opportunities
The rising prevalence of hepatitis E across the world is the leading factor behind the growth of the hepatitis E diagnostic tests market. According to statistics of the WHO, almost 20 million people suffer from HEV infections each year, worldwide, of which nearly 3.3 million are symptomatic cases.
Some primary hepatitis E diagnostic tests are ELISA HEV IgM, RT-PCR, and ELISA HEV IgG. Of them, ELISA HEV IgM test kits account for the maximum demand due to the soaring incidence of hepatitis E worldwide; the demand for ELISA HEV IgM test kits is predicted to remain significantly high over the forecast period. The demand for RT-PCR test kits is likely to closely trail that of ELISA HEV IgM test kits in the upcoming years. The demand for RT-PCR is mainly because it delivers fast results and high sensitivities and specificities of molecular assay. The segment of ELISA HEV IgG, on the other hand, is likely to display a modest growth over the report’s forecast period.
Ask An Expert @ https://www.tmrresearch.com/sample/sample?flag=ASK&rep_id=3077
Although the hepatitis E diagnostic tests market currently seems to be teeming with opportunities, the increasing prevalence of asymptomatic diseases, which are difficult to be detected, may pose severe growth challenges to this market. Furthermore, low level of awareness about therapeutics for Hepatitis E is also anticipated to hamper the growth of this market in the long run.
Global Hepatitis E Diagnostic Tests Market: Geographical Analysis
The global market for hepatitis E diagnostic tests is divided into the key regions of North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. On account of the high prevalence of hepatitis E in Asian countries such as India, Nepal, Pakistan, Bangladesh, Burma, Thailand, and Vietnam, Asia Pacific has emerged as the dominant regional segment for hepatitis E diagnostic tests and is predicted to continue to remain so in the years ahead too. This regional market is projected to hold more than 48% share in the overall market by the end of 2024.
Read Comprehensive Overview of Report@ https://www.tmrresearch.com/hepatitis-e-diagnostic-tests-market
Besides this, the Middle East and Africa are likely to emerge as a key market for hepatitis E diagnostic tests in the forthcoming years. Lack of safe drinking water and poor sanitation in countries such as Kenya, Nigeria, Morocco, and Uganda are reasons behind increasing prevalence of hepatitis E.
Global Hepatitis E Diagnostic Tests Market: Companies Mentioned
Some of the core companies in the hepatitis E diagnostic tests market are Beijing Wantai Biological Pharmacy, Mikrogen GmBH, Fast-track diagnostics Ltd., Hoffmann-La Roche Ltd., Altana Diagnostics GmbH, Primerdesign Ltd., MP Biomedicals LLC, Fortress Diagnostics Ltd., and Biokit S.A.
About Us
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.
Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.
Contact:
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis E Diagnostic Tests Market Rugged Expansion Foreseen by 2024 here
News-ID: 943112 • Views: …
More Releases from TMR Research
Automotive Vision System Market Share and Growth Factors Impact Analysis 2021 - …
Automotive Vision System Market: Introduction
A system that increases the vehicle driver's perception during night or bad weather conditions is termed as Automotive night vision system (ANVS). The system is otherwise beyond the reach of the vehicle's headlights, thereby prevents accidents at night. It can also be defined as a system which assists the driver by increasing visibility during bad whether while providing safety. Vehicle which have automotive vision system integrated are…
Waste Heat Recovery Market Competitive Landscape Analysis with Forecast by 2031
Waste Heat Recovery Market: Snapshot
The waste heat recovery market has been expected to reach a valuation of US$ 65.87 Bn and expand at a CAGR of 6.90% in the foreseeable years from 2020 to 2030.
The growth opportunities in the waste heat recovery market are attributed to the increasing prices of electricity and energy in the emerging economies. In addition to this, government regulations and incentives are also estimated to contribute…
Physical Fitness Equipment Market Current Trends and Future Aspect Analysis | Ma …
Global Physical Fitness Equipment Market: Snapshot
The physical fitness equipment market has been expected to reach a valuation of US$ 14.8 Bn and expand at a CAGR of 3.3% in the foreseeable years from 2020 to 2030.
The revenue generation opportunities in the physical fitness equipment market are attributed to the increasing enthusiasm among people toward fitness. In recent years, the fitness industry has been growing at a noticeable speed owing to…
Molecular Spectrometry Market Competitive Analysis and Forecast 2021-2031 | Grow …
Global Molecular Spectrometry Market: Snapshot
Molecular spectrometry examines and quantifies the response of molecules on interaction with known amounts of energy. Molecules have some energy levels that can be studied by determining the molecule's energy exchange through emission or absorbance. Molecular spectrometry involves studying emission, absorption, or scattering of electromagnetic waves by atoms or molecules to quantitatively and qualitatively study atoms, molecules or physical processes. The interaction of matter with radiation…
More Releases for Hepatitis
Is Hepatitis A Vaccine Required?
Hepatitis A Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available…
Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis …
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Hepatitis B Therapeutics Market Is Driven by Rising Incidence of Hepatitis B In …
Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and…
Hepatitis E Hyperendemicity to Drive Hepatitis E Diagnostic Tests Market Growth
Global Hepatitis E Diagnostic Tests Market: Snapshot
The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene,…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each…
